Skip to content

Oral Versus Rectal Ibuprofen for Fever in Young Children - a Randomized Control Study.

Oral Versus Rectal Ibuprofen for Fever in Young Children - a Randomized Control Study.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00729976
Enrollment
40
Registered
2008-08-08
Start date
2008-09-30
Completion date
2011-06-30
Last updated
2011-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fever

Keywords

Ibuprofen, Suppository, febrile children

Brief summary

Fever is one of the most common symptoms in pediatrics and one of the most common reasons for visits in pediatricians' office and pediatric emergency departments. Many parents consider fever to be the most terrifying symptom. Ibuprofen is an effective and safe treatment for febrile children. Until recently ibuprofen was available only in tablets suspension and as a liquid gel. All these dosage form are administered orally. Rectal suppositories are often essential for treating febrile children who cannot take medications by mouth (e.g vomiting). In the current study we aim to compare the effect on fever of ibuprofen given as suspension with ibuprofen suppositories.

Interventions

5-10mg/Kg of ibuprofen

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Months to 5 Years
Healthy volunteers
No

Inclusion criteria

Age: 3 mo- 4 years * Weight 6 - 18 kg * Rectal temperature \> 38.50

Exclusion criteria

* Treatment with acetaminophen in the last 4 hours * Treatment with Ibuprofen in the last 6 hours * Unable to take oral or rectal medications * Hypersensitivity to ibuprofen * Renal failure * Liver disease * Rectal temperature can't be measured (due to anatomical or medical problem) * Informed consent could not be granted

Design outcomes

Primary

MeasureTime frame
Maximal change in temperature during the 4-hour period after enrollment.4 hours

Secondary

MeasureTime frame
Proportion of patients with a drop of at least 1°C and 2°C in mean temperature at 4h. Decrement in fever at each time point, and the area under the temperature (versus time) curve. Proportion of patients with temperature < 38 at 4 hours.4 h

Countries

Israel

Contacts

Primary ContactEran Kozer, MD
erank@asaf.health.gov.il972 8 9779916
Backup ContactEhud Rosenbloom, MD
ehudroze@gmail.com972 8 9779916

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026